This is a Validated Antibody Database (VAD) review about dog KAT2B, based on 7 published articles (read how Labome selects the articles), using KAT2B antibody in all methods. It is aimed to help Labome visitors find the most suited KAT2B antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KAT2B synonym: PCAF; histone acetyltransferase KAT2B; p300/CBP-associated factor
Abcam
rabbit polyclonal |
| In order to explore transcriptional regulation mediated by p27, Pax5, and PCAF, Abcam KAT2B antibody (Abcam, ab12188) was used in ChIP-Seq on human samples (fig 3e) and in immunoprecipitation on human samples (fig s8c). Nucleic Acids Res (2017) ncbi |
rabbit polyclonal |
| Abcam KAT2B antibody (Abcam, ab12188) was used in chromatin immunoprecipitation on human samples (fig 4) and in western blot on human samples (fig 4). Nucleic Acids Res (2016) ncbi |
rabbit polyclonal |
| Abcam KAT2B antibody (Abcam, ab12188) was used in chromatin immunoprecipitation on human samples and in western blot on human samples . Am J Physiol Regul Integr Comp Physiol (2014) ncbi |
rabbit polyclonal |
| Abcam KAT2B antibody (Abcam, ab12188) was used in immunohistochemistry on human samples at 1:500 (fig 2, 3). Cell Rep (2014) ncbi |
rabbit polyclonal |
| Abcam KAT2B antibody (Abcam, ab12188) was used in chromatin immunoprecipitation on human samples . Mol Cell Biol (2014) ncbi |
rabbit polyclonal |
| Abcam KAT2B antibody (Abcam, ab12188) was used in chromatin immunoprecipitation on human samples . BMC Cancer (2013) ncbi |
rabbit polyclonal |
| Abcam KAT2B antibody (Abcam, ab12188) was used in immunoprecipitation on mouse samples and in western blot on mouse samples (fig 5). PLoS ONE (2012) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments